Drug Shortage Report for POTASSIUM ACETATE INJECTION USP

Last updated on 2021-11-30 History
Report ID 143559
Drug Identification Number 02362597
Brand name POTASSIUM ACETATE INJECTION USP
Common or Proper name Potassium Acetate Injection
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) POTASSIUM ACETATE
Strength(s) 39.2%
Dosage form(s) LIQUID
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 x 50mL vial / fiole
ATC code B05XA
ATC description I.V. SOLUTION ADDITIVES
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2021-08-05
Estimated end date 2021-11-30
Actual end date 2021-11-29
Shortage status Resolved
Updated date 2021-11-30
Company comments Product on Allocation. U.S. Government implementing the Defense Production Act which will affect the supply of API to Canada.
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2021-11-30 French Compare
v8 2021-11-30 English Compare
v7 2021-11-12 French Compare
v6 2021-11-12 English Compare
v5 2021-11-11 French Compare
v4 2021-11-11 English Compare
v3 2021-08-06 English Compare
v2 2021-08-04 French Compare
v1 2021-08-04 English Compare

Showing 1 to 9 of 9